NeoGenomics: Vishal Sikri

NeoGenomics announced that Vishal Sikri will take over as president and chief commercial officer of its subsidiary Inivata on May 23. Sikri was most recently president of oncology at Invitae and previously served as SVP of oncology product strategy and management at the company. Before that, he was US general manager at Biocartis and VP of commercial operations at liquid biopsy company Sysmex Inostics. 

NeoGenomics also announced the departure of Gina Wallar, the firm's president of the pharma services division, effective May 27. Jennifer Rose, VP of pharma sales and project management operations, will take over in the interim.